Development and validation of simple spectrophotometric and chemometric methods for simultaneous determination of empagliflozin and metformin: Applied to recently approved pharmaceutical formulation

New univariate spectrophotometric method and multivariate chemometric approach were developed and compared for simultaneous determination of empagliflozin and metformin manipulating their zero order absorption spectra with application on their pharmaceutical preparation. Sample enrichment technique...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy Ročník 168; s. 118 - 122
Hlavní autor: Ayoub, Bassam M.
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Elsevier B.V 05.11.2016
Témata:
Benzhydryl Compounds - analysis
Chemometry
Empagliflozin
Glucosides - analysis
Hypoglycemic Agents - analysis
Least-Squares Analysis
Limit of Detection
Metformin
Metformin - analysis
Partial least squares
Pharmaceutical preparation
Simultaneous equation
Spectrophotometry - methods
Tablets
Pharmaceutical preparation
Empagliflozin
Metformin
Chemometry
Partial least squares
Simultaneous equation
ISSN:1386-1425, 1873-3557, 1873-3557
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:New univariate spectrophotometric method and multivariate chemometric approach were developed and compared for simultaneous determination of empagliflozin and metformin manipulating their zero order absorption spectra with application on their pharmaceutical preparation. Sample enrichment technique was used to increase concentration of empagliflozin after extraction from tablets to allow its simultaneous determination with metformin without prior separation. Validation parameters according to ICH guidelines were satisfactory over the concentration range of 2–12μgmL−1 for both drugs using simultaneous equation with LOD values equal to 0.20μgmL−1 and 0.19μgmL−1, LOQ values equal to 0.59μgmL−1 and 0.58μgmL−1 for empagliflozin and metformin, respectively. While the optimum results for the chemometric approach using partial least squares method (PLS-2) were obtained using concentration range of 2–10μgmL−1. The optimized validated methods are suitable for quality control laboratories enable fast and economic determination of the recently approved pharmaceutical combination Synjardy® tablets. [Display omitted] •Simultaneous determination of empagliflozin and metformin•First spectrophotometric method for determination of empagliflozin and metformin•First chemometric method for determination of empagliflozin•Applicable on recently approved pharmaceutical dosage form•The proposed method is suitable for QC laboratories
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1386-1425
1873-3557
1873-3557
DOI:10.1016/j.saa.2016.06.010